Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Lewis BryanDirector, CEO/President | Open-market sale · 10b5-1 plan | SELL | $85K 10.0K sh | Apr 21, 2026 |
| 8 | Lodge-Jarrett JulieEVP, Chf People & Purpose Ofcr | Gift | G | — 150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Priest Brady PatrickCEO of Clover Care Services | Tax withholding | F | $79K 36.1K sh | Apr 21, 2026 traded Apr 18, 2026 |
| 8 | Ames Sophie CExec. Vice President & CHRO | Open-market sale · 10b5-1 plan | SELL | $66K 3,070 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Gibbons Mary LourdesSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $55K 872 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $806K 1,398 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $115K 2,419 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 8 | Garateix Ernie JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $221K 8,034 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 8 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $885K 1,543 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 7 | Gibbons Mary LourdesSVP and Chief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $481K 7,628 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 7 | Llewellyn Lindsay CatherineSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $355K 23.7K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Binder Kurtis JosephCHIEF FINANCIAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $380K 25.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Bradbury Robyn LChief Financial Officer | Derivative conversion · 10b5-1 plan | C | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Sharma PankajChief Business Officer | Option exercise · 10b5-1 plan | M | — 10.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 7 | Riese Phillip JohnDirector | Option exercise · 10b5-1 plan | M | $26K 40.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS | Open-market sale · 10b5-1 plan | SELL | $26K 536 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Pearson MarkDirector, President and CEO | Option exercise · 10b5-1 plan | M | $630K 27.2K sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Modi Rajeev A.SEE REMARKS | Grant or award | A | $1,477 62 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Ganesan SatishSee Remarks | Tax withholding · 10b5-1 plan | F | $470K 5,862 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 5 | Garateix Ernie JDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $8,521 300 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 5 | Gupta VikramSee Remarks | Tax withholding · 10b5-1 plan | F | $443K 5,518 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $589K 1,009 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $289K 500 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $581K 1,010 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $573K 983 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Hoffmann MartinCEO | Open-market sale · 10b5-1 plan | SELL | $152K 4,150 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $254K 442 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $397K 687 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $504K 880 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $284K 488 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 4 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $282K 482 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 3 | Rodman David MalcomChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $13K 416 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Atkinson NajumaDirector | Option exercise · 10b5-1 plan | M | — 30.9K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Option exercise · 10b5-1 plan | M | $12K 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 3 | Riese Phillip JohnDirector | Option exercise · 10b5-1 plan | M | — 40.0K sh | Apr 21, 2026 traded Apr 17, 2026 |
| 2 | Wren ChrisVP of Operations | Grant or award · 10b5-1 plan | A | — 822.0K sh | Apr 21, 2026 traded Apr 16, 2026 |
| 2 | Bradbury Robyn LChief Financial Officer | Other acquisition or disposition · 10b5-1 plan | J | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 2 | Bradbury Robyn LChief Financial Officer | Other acquisition or disposition · 10b5-1 plan | J | — 5,000 sh | Apr 21, 2026 traded Apr 17, 2026 |
| 1 | Edgemond JamesCFO AND TREASURER | Open-market sale · 10b5-1 plan | SELL | $197K 340 sh | Apr 21, 2026 traded Apr 20, 2026 |
| 1 | Collins Helen LouiseCHIEF MEDICAL OFFICER | Open-market sale · 10b5-1 plan | SELL | $6,413 140 sh | Apr 21, 2026 traded Apr 17, 2026 |